This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor:
—In the April issue of the Archives, under "Correspondence," there was published a letter on "Aureomycin in the Treatment of Virus Diseases," by George A. Sheehan Jr., M.D. Dr. Sheehan reported the local use of aureomycin in a case of "conjunctivitis of supposed Newcastle disease."Aureomycin is undoubtedly a beneficial therapeutic agent in the treatment of virus diseases. However, in January 1950, I had under my care a proved case of Newcastle's conjunctivitis which occurred in a virologist. My associates and I were able to demonstrate inclusion bodies within the epithelial cells both before and after the administration of aureomycin drops, and we found that the drug in no way altered the course of the disease, the presence of which, I repeat, was verified in this case by virologic studies.The inclusion bodies were demonstrable in scrapings, but not in smears, of the conjunctiva, and the disease
Gettes BC. AUREOMYCIN IN TREATMENT OF VIRUS DISEASES. Arch Ophthalmol. 1950;43(6):1088. doi:10.1001/archopht.1950.00910011105014